Cigna Group (NYSE:CI) Receives $331.83 Average Target Price from Brokerages

Cigna Group (NYSE:CIGet Free Report) has received a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $331.8261.

A number of brokerages have commented on CI. Morgan Stanley restated an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a research report on Friday, October 31st. Sanford C. Bernstein reduced their target price on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating for the company in a report on Wednesday, November 12th. Leerink Partners lowered their price target on shares of Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. JPMorgan Chase & Co. dropped their price target on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research report on Tuesday, November 4th. Finally, Barclays decreased their price objective on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating on the stock in a research report on Friday, October 31st.

View Our Latest Stock Report on Cigna Group

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CEO David Cordani acquired 4,134 shares of the company’s stock in a transaction dated Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer directly owned 157,935 shares in the company, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Harbor Capital Advisors Inc. grew its holdings in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 49 shares in the last quarter. Flaharty Asset Management LLC purchased a new position in Cigna Group during the first quarter valued at $28,000. 1248 Management LLC purchased a new position in Cigna Group during the first quarter valued at $29,000. Solstein Capital LLC bought a new stake in Cigna Group in the 2nd quarter valued at $29,000. Finally, Activest Wealth Management lifted its stake in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Up 1.4%

CI opened at $278.95 on Monday. The firm’s 50 day simple moving average is $272.29 and its two-hundred day simple moving average is $289.92. The company has a market capitalization of $74.52 billion, a PE ratio of 12.30, a PEG ratio of 0.98 and a beta of 0.26. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. During the same period in the prior year, the business posted $7.51 EPS. Cigna Group’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were issued a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.